Personalized dietitian coaching with digital farmers market to improve blood pressure
Official title: Integrating Free-choice Marketplace, dieTitian coacHing, cultuRally Tailored messagIng to improVE Blood Pressure
Run by Johns Hopkins University · NCT07075588 · Data updated 2026-11-12
This trial tests if digital farmacy, tailored dietitian guidance, produce prescriptions, and home blood pressure monitoring can help Black and Hispanic adults with high blood pressure in Maryland.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 70 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Johns Hopkins University Academic / other |
| Locations | 3 sites (Baltimore, Maryland and 2 other locations) |
| Status | Recruiting |
| Started | June 25, 2026 |
| Main results expected | April 30, 2027 |
| Study ends | March 20, 2028 |
| Registry record updated | June 30, 2026 |
| Trial ID | NCT07075588 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 21-70 who identify as Black/African American or Hispanic/Latino, have Stage 2 CKM with elevated BP, and live in Maryland HFPA regions with limited access to healthy foods.
✕Probably not a fit
Individuals without the targeted CKM profile or outside the HFPA criteria may not benefit from the intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
iTHRIVE is a two-arm randomized trial enrolling 21-70 year-olds who are Black/African American or Hispanic/Latino with hypertension and related CKM conditions. Participants receive digital access to produce prescriptions and culturally tailored dietitian coaching plus home blood pressure monitoring, with an active comparator to standard care. The study focuses on residents in high food priority areas to address disparities in CKM-related health. Outcomes will relate to blood pressure, diet, and metabolic markers, with emphasis on access and adherence to nutritious food choices. The trial is led by Johns Hopkins University with collaborations from the AHA and NIMHD and takes place at affiliated Maryland sites.
Why it matters
Potential benefit: If successful, participants may experience better blood pressure control and improved access to healthy foods through a digital Farmers Market and personalized coaching.
How similar studies have gone: Prior research supports the promise of personalized dietitian coaching and home BP monitoring, though digital FARMacy approaches in this specific population are novel but build on established components.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 21-70 years * Self-identify as Black/African American or Hispanic/Latino * Have Stage 2 CKM defined as: * Systolic BP ≥130mmHg (measured at screening) AND at least one of: * Hypertension (ICD-10: I10-I16) * Prediabetes (HbA1c 5.7-6.4%) or Type 2 Diabetes (HbA1c ≥6.5%) * Stage 3 chronic kidney disease (CKD) (eGFR 30-59 mL/min/1.73m²) * Live in census tracts identified by the Montgomery/ Prince George's/Baltimore City County Departments of Planning as HFPA: * Healthy Food Availability Index score is low (0-9.5), * Median household income ≤185% of Federal Poverty Level * 30% of households have no vehicle, * Distance to supermarket \>1/4 mile. 5. Have refrigeration, food preparation appliances (microwave, stove), and cell phones for the App Exclusion Criteria: * Age \<21 years * Diagnosis of end-stage renal disease (ESRD), dialysis * Serious medical condition that either limits life expectancy or requires active management (e.g., cancer) * Significant food allergies, preferences, intolerances, or dietary requirements that would interfere with diet adherence * Active alcohol or substance use disorder (i.e., not sober/abstinent for ≥ 30 days) * Patients with cognitive impairment or other condition preventing their participation in the intervention * Pregnant, breastfeeding, or planning pregnancy * Current participation in a care management program related to health conditions (e.g., weight reduction, smoking cessation) or another clinical trial that could interfere with the study protocol * Planning to move out of the geographic area in 12 months
Where it's running
-
Johns Hopkins Community Physicians
Baltimore, Maryland, United States Recruiting -
Johns Hopkins School of Nursing
Baltimore, Maryland, United States Not yet recruiting -
Holy Cross Hospital
Gaithersburg, Maryland, United States Not yet recruiting
Study contacts
- Principal investigator: Oluwabunmi Ogungbe, PhD, MPH, RN — Johns Hopkins School of Nursing
- Study coordinator: Oluwabunmi Ogungbe, PhD, MPH, RN
- Email: oogungb3@jh.edu
- Phone: 410-614-1519
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Hypertension: Does Education Help Patients Manage Blood Pressure Better?
This study tests whether structured patient education improves blood pressure control and self-management in adults with hypertension who speak Turkish.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Long-term GW906 treatment for people with essential hypertension
This trial tests whether long-term GW906 injections are safe and effective for adults with essential hypertension who completed an earlier GW906 study.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.